Pursuant to Regulation 29 read with Regulation 47 of the Securities and Exchange Board of India (listing Obligations and Disclosure Requirements) Regulations, 2015, Makers Laboratories has informed that a meeting of the Board of Directors of the Company will be held on Monday, 14th November, 2022, to consider and take on record the Unaudited Financial Results for the 2nd quarter and half year ended 30th September, 2022 of the financial year 2022-23. Further, with reference to the above meeting of the Board of Directors, it has already informed vide its letter dated 30th September, 2022 that the trading window for dealing in the securities of the Company by the Insiders as defined under the SEBI (Prohibition of Insider Trading) Regulations, 2015 shall remain closed with immediate effect and until 48 hours after the declaration of the unaudited financial results till 16th November, 2022.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1709.40 |
Dr. Reddys Lab | 1109.75 |
Cipla | 1415.55 |
Lupin | 1971.10 |
Zydus Lifesciences | 866.65 |
View more.. |